Hims & Hers Introduces MedMatch, The Next Generation of Intelligent  Diagnostic Services

Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services

4.9
(596)
Write Review
More
$ 24.99
Add to Cart
In stock
Description

SAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS), the leading health and wellness platform, today introduced MedMatch, a technology designed to transform healthcare by giving providers a more intelligent and informed way to deliver personalized care to patients with more effective and precise treatments and medications.
SAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. (Hims & Hers or the Company) (NYSE: HIMS), the leading health and wellness platform, today

MCE Fuels AI Chatbot Performance With Real-Time Device Data and Intelligence

McAfee Launches Powerful New Online Protection Solution for Small

Hims & Hers Health Stock (NYSE:HIMS), Quotes and News Summary - Benzinga

Stevanato Group Collaborates with Recipharm to Develop and

Dedicated CPS workers earn praise, Brazos Living

Hims&Hers kolmessa vuodessa kannattavaksi - Osakkeet - Osakesijoittaminen

hims & hers - A Model For Better Care Through Patient Engagement and Telemedicine

MedMatch - Crunchbase Company Profile & Funding

Hims & Hers Health, Inc. (HIMS) Stock Price, Quote & News - Stock Analysis